Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016
Price:
23.69
CNY
4.64%
Market Closed
Market Cap:
¥10B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016
|
CN |
|
K
|
Kiwoom Securities Co Ltd
KRX:039490
|
KR |
|
Renovare Environmental Inc
OTC:RENO
|
US |
|
A
|
AMP Ltd
NZX:AMP
|
AU |
|
Camus Engineering & Construction Inc
KRX:013700
|
KR |
|
Siemens Energy AG
XETRA:ENR
|
DE |
|
D
|
Duniec Bros Ltd
TASE:DUNI
|
IL |
|
Sebang Global Battery Co Ltd
KRX:004490
|
KR |
|
Texaf SA
XBRU:TEXF
|
BE |
|
C
|
Contact Energy Ltd
ASX:CEN
|
NZ |
|
P
|
Poolbeg Pharma PLC
LSE:POLB
|
UK |
|
C
|
Carpenter Tan Holdings Ltd
HKEX:837
|
CN |
|
Hung Hing Printing Group Ltd
HKEX:450
|
HK |
|
ONEOK Inc
NYSE:OKE
|
US |
|
Hainan Yedao Group Co Ltd
SSE:600238
|
CN |
|
L
|
Larsen & Toubro Ltd
BSE:500510
|
IN |
|
P
|
Powdertech Co Ltd
TSE:5695
|
JP |
|
G
|
G Energy SA
WSE:GNG
|
PL |
|
G
|
Grand House Mulia Tbk PT
IDX:HOMI
|
ID |
|
Jyoti Ltd
BSE:504076
|
IN |
|
Brookfield Business Partners LP
NYSE:BBU
|
BM |
|
E
|
Encanto Potash Corp
XTSX:EPO.H
|
CA |
|
Miroku Corp
TSE:7983
|
JP |
|
CIFI Holdings (Group) Co Ltd
HKEX:884
|
CN |
Cash Flow Statement
Cash Flow Statement
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Cash Taxes Paid |
(1)
|
3
|
(2)
|
(10)
|
(12)
|
(18)
|
(20)
|
(15)
|
(13)
|
(1)
|
10
|
(1)
|
2
|
3
|
|
| Change in Working Capital |
(106)
|
(81)
|
(64)
|
(63)
|
(56)
|
(69)
|
(74)
|
(100)
|
(110)
|
(84)
|
(92)
|
(45)
|
(43)
|
(78)
|
|
| Cash from Operating Activities |
101
N/A
|
143
+41%
|
141
-1%
|
150
+6%
|
167
+12%
|
191
+14%
|
187
-2%
|
195
+4%
|
201
+3%
|
190
-5%
|
217
+14%
|
301
+38%
|
338
+12%
|
384
+13%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(110)
|
(156)
|
(181)
|
(176)
|
(176)
|
(221)
|
(257)
|
(312)
|
(324)
|
(230)
|
(283)
|
(282)
|
(302)
|
(397)
|
|
| Other Items |
(192)
|
(233)
|
45
|
(71)
|
(25)
|
(26)
|
63
|
88
|
4
|
40
|
(5)
|
109
|
48
|
93
|
|
| Cash from Investing Activities |
(302)
N/A
|
(389)
-29%
|
(136)
+65%
|
(247)
-81%
|
(201)
+19%
|
(246)
-22%
|
(194)
+21%
|
(224)
-16%
|
(319)
-43%
|
(190)
+41%
|
(288)
-52%
|
(173)
+40%
|
(254)
-47%
|
(304)
-20%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Debt |
0
|
0
|
0
|
(1)
|
49
|
49
|
49
|
0
|
10
|
20
|
20
|
10
|
90
|
233
|
|
| Cash Paid for Dividends |
(1)
|
(6)
|
(10)
|
(11)
|
(11)
|
(37)
|
(32)
|
(32)
|
(32)
|
(59)
|
(68)
|
(78)
|
(78)
|
(67)
|
|
| Other |
413
|
9
|
7
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(3)
|
|
| Cash from Financing Activities |
362
N/A
|
(38)
N/A
|
(0)
+100%
|
(13)
-6 969%
|
36
N/A
|
11
-70%
|
15
+35%
|
(34)
N/A
|
(24)
+29%
|
(41)
-69%
|
(50)
-22%
|
(70)
-42%
|
9
N/A
|
163
+1 637%
|
|
| Change in Cash | |||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(2)
|
|
| Net Change in Cash |
161
N/A
|
(284)
N/A
|
4
N/A
|
(110)
N/A
|
3
N/A
|
(44)
N/A
|
8
N/A
|
(63)
N/A
|
(143)
-126%
|
(40)
+72%
|
(120)
-197%
|
57
N/A
|
93
+65%
|
241
+158%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(8)
N/A
|
(13)
-61%
|
(40)
-200%
|
(26)
+36%
|
(9)
+66%
|
(29)
-234%
|
(70)
-138%
|
(117)
-68%
|
(123)
-5%
|
(40)
+68%
|
(65)
-64%
|
19
N/A
|
36
+88%
|
(13)
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
